Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

Clinical trial NCT05143840 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05143840
Sponsor: University of Alabama at Birmingham
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia, Chronic Phase Adult CML Leukemia, Myeloid Leukemia,Myeloid, Chronic

Start date: 2022-04-22
Primary completion: 2032-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.